CIK: 1634632 - Address: 1700 Owens Street, Suite 595, San Francisco, CA 94158
19 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
5/17/22 17:12
5/13/22
CMPICheckmate Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagVenbio Global Strategic Fund II L.P.CATS.m-1,37610.450-132-62,156D
5/12/22 20:47
5/10/22
CMPICheckmate Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagVenbio Global Strategic Fund II L.P.CATS.m-1,67210.390-161-72,288D
5/9/22 18:58
5/5/22
CMPICheckmate Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagVenbio Global Strategic Fund II L.P.CATS.m-89910.370-87-32,448D
5/4/22 19:30
5/2/22
CMPICheckmate Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagVenbio Global Strategic Fund II L.P.CATS.m-2,80910.380-271-102,535D
4/29/22 17:50
4/27/22
CMPICheckmate Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagVenbio Global Strategic Fund II L.P.CATS.m-1,97310.380-190-62,806D
4/26/22 18:40
4/22/22
CMPICheckmate Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagVenbio Global Strategic Fund II L.P.CATS.m-1,34810.390-130-42,996D
4/21/22 20:54
4/19/22
CMPICheckmate Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagVenbio Global Strategic Fund II L.P.CATS.m-5,70010.410-548-153,126D
7/6/20 19:00
7/1/20
AKROAkero Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVenbio Global Strategic Fund II L.P.CATS.m-4,00734.400-116-43,034I
3/6/20 17:23
3/4/20
AKROAkero Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVenbio Global Strategic Fund II L.P.CATS.m-1,09223.760-46-13,150I
3/3/20 17:52
2/28/20
AKROAkero Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVenbio Global Strategic Fund II L.P.CATS.m-49322.630-22-13,196I
2/27/20 19:51
2/25/20
AKROAkero Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVenbio Global Strategic Fund II L.P.CATS.m-13522.800-603,228I
2/12/20 17:56
2/10/20
AKROAkero Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVenbio Global Strategic Fund II L.P.CATS.m-27127.070-1003,234I
2/10/20 17:47
2/6/20
AKROAkero Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVenbio Global Strategic Fund II L.P.CATS-16527.030-603,234I
2/6/20 16:06
2/4/20
AKROAkero Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVenbio Global Strategic Fund II L.P.CATS.m-2,12225.770-82-23,240I
1/14/20 08:58
1/13/20
AKROAkero Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVenbio Global Strategic Fund II L.P.CATS-9,99420.230-494-133,322I
1/10/20 16:06
1/8/20
AKROAkero Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVenbio Global Strategic Fund II L.P.CATS-31119.860-1603,816I
1/8/20 16:10
1/6/20
AKROAkero Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVenbio Global Strategic Fund II L.P.CATS.m-1,45519.860-73-23,832I
1/6/20 16:07
1/2/20
AKROAkero Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVenbio Global Strategic Fund II L.P.CATS.m-70019.710-35-13,905I
1/3/20 16:13
12/31/19
AKROAkero Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVenbio Global Strategic Fund II L.P.CATS-34323.960-1403,941I

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact